Equiplex

What Equiplex does

Equiplex Indústria Farmacêutica Ltda. is a Brazilian sterile-injectables manufacturer founded in 1986 in Goiânia and headquartered in Aparecida de Goiânia (state of Goiás). The company produces large-volume (50–1000mL bottles) and small-volume (10mL ampoules) parenteral solutions, including glucose solutions (5%, 25%, 50%, 75%), sodium chloride solutions (0.9% and concentrated forms), potassium chloride, Ringer's lactate and simple solutions, mannitol 20%, glycerin 12%, water for injection, and enteral nutrition bottles. Manufacturing relies on imported European technology: German Blow Fill Seal for small-volume aseptic filling, Italian systems for large-volume bottle filling, French ScanRDI rapid sterility testing, and US HPLC Infinity 3 analytics, with GS1 DataMatrix ECC 200 traceability across all SKUs (compliant with ANVISA RDC 157/2017). The facility produces more than 350 million units annually.

The company sells B2B to a domestic and international institutional customer base: hospitals, clinics, emergency care units (UPAs), municipal and state health secretariats, and pharmacies. Distribution is executed through a state-by-state field representative network covering all Brazilian states, supplemented by its wholly-owned group distributor Hospdrogas and by export partners serving twelve or more countries across South America, Central America, North America, Europe, the Middle East, and Asia. Notable prior institutional engagements include supplying injectable medications to Pfizer and the Pan-American Health Organization (PAHO) during the COVID-19 response, covering eight Latin American countries. Pricing is negotiated in institutional procurement and tender processes; no public price list exists. The company is privately held and controlled by the diversified Brazilian H. Egidio Group.

Equiplex entered a transformation phase beginning with the September 2024 inauguration of its first R&D laboratory (R$ 5 million initial investment, 17-person multidisciplinary team), followed by the November 2025 appointment of Massillon Araujo as CEO (prior experience at EMS, Hypera, Cristália, and Lupin) and the November 2025 full deployment of GS1 DataMatrix serialization. Strategic priorities include entry into generic and similar medications (antibiotics, antifungals, antiemetics, anti-inflammatories) with first launches targeted for 2027, a planned 2026 doubling of R&D capacity, and geographic expansion to Mexico, Chile, and Colombia beyond the existing Argentina and Paraguay footprint.

Name

Equiplex

Legal name

EQUIPLEX INDÚSTRIA FARMACÊUTICA LTDA.

Website

https://equiplex.com.br

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Equiplex is a Brazilian pharmaceutical manufacturer founded in 1986, producing 350M+ units annually of sterile injectable solutions (glucose, saline, Ringer's, mannitol) for hospitals, clinics, public health systems, and export markets across 12+ countries, with a new R&D push into generic medications.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sterile Injectable Generics (HLAIABAC)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Injectable solutions
• Parenteral medications
• Hospital drug supplies
• Generic medications

Headquarters

HQ city

Goiânia

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and sale of parenteral solutions (large and small volume), including glucose solutions, saline solutions, Ringer's solutions, mannitol, glycerin, and water for injection. B2B sales to hospitals, clinics, health departments, and distributors.
2. Generic and Similar Medicines: New product line expansion into generic and similar medications including antibiotics, antifungals, antiemetics, and anti-inflammatories, produced for own brand and under demand for group distributor Hospdrogas. First launches expected in 2027.
3. International Export: Export of pharmaceutical products to 12+ countries including Argentina, Paraguay, Dominican Republic, Venezuela, Colombia, Peru, Bolivia, Uruguay, Chile, Netherlands, Germany, Israel, and China.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Equiplex manufactures and sells sterile parenteral (injectable) solutions in large volume (50-1000mL bottles) and small volume (10mL ampoules) formats. The product portfolio includes glucose solutions, sodium chloride solutions, potassium chloride, Ringer's solutions, mannitol, glycerin, water for injection, and enteral nutrition bottles. Products are sold to hospitals, clinics, emergency care units, government health departments, and pharmaceutical distributors in Brazil and 12+ international markets.

Product overview

Equiplex is a Brazilian pharmaceutical company with 39 years of experience producing parenteral medications of large and small volume. The company operates with German and Italian manufacturing technology and produces a portfolio of injectable solutions including glucose solutions (5%, 25%, 50%, 75%), sodium chloride solutions (0.9% and concentrated forms), potassium chloride, Ringer's solutions (with lactate and simple), mannitol, glycerin, water for injection, and enteral nutrition bottles. The company is expanding into generics and similar medications through its new R&D laboratory inaugurated in September 2024, with initial investment of R$ 5 million. Products are categorized as large volume (50-1000mL bottles) and small volume (10mL ampoules) solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Solução de Glicose 75% (Glucose Solution 75%) Hypertonic glucose solution used as a sclerosing agent for treating microvarices and telangiectasias in sclerotherapy procedures. Sold to healthcare facilities.
• Solução de Glicose 25% e 50% (Glucose Solution 25% and 50%) Injectable glucose solutions providing calories and nutrients, used for treating hypoglycemic conditions and as a water source for hydration. Sold to hospitals and clinics.
• Solução de Glicose 5% (Glucose Solution 5%) Injectable glucose solution serving as a source of water, calories, and osmotic diuresis, indicated for dehydration, caloric replacement, hypoglycemia, and as a vehicle for compatible medications.
• Água para Injeção (Water for Injection) Sterile, apyrogenic injectable water used as a diluent and dissolution medium for medications according to medical prescription. Sold to hospitals and pharmacies.
• Água para Injeção 10ml (Water for Injection 10ml) Sterile, apyrogenic, hypotonic injectable solution in ampoules and bottles used for dilution and dissolution of medications.
• Solução de Cloreto de Sódio 0.9% (Sodium Chloride Solution 0.9%) Physiological sodium chloride solution for fluid and electrolyte replacement, sodium deficiency, and as a diluent for injectable medications.
• Solução Fisiológica de Cloreto de Sódio (Physiological Sodium Chloride Solution) Injectable sodium chloride solution in various concentrations (10%, 17.55%, 20%) for electrolyte replacement, metabolic alkalosis, and sodium deficiency.
• Solução de Cloreto de Potássio (Potassium Chloride Solution) Electrolyte replacement solution containing potassium and chloride ions, used for treating hypokalemia, metabolic alkalosis, and digitalis intoxication.
• Solução Glicofisiológico (Glycophysiological Solution) Combined glucose and sodium chloride solution (5% glucose + 0.9% sodium chloride) for fluid, electrolyte, and calorie replacement in dehydration, diarrhea, burns, and post-operative care.
• Solução de Manitol 20% (Mannitol Solution 20%) Osmotic diuretic solution for promoting diuresis, preventing acute renal failure, reducing intracranial and intraocular pressure, and treating cerebral edema.
• Solução de Ringer com Lactato (Ringer's Lactate Solution) Balanced electrolyte solution containing sodium, potassium, calcium, chloride, and lactate for rehydration and treatment of metabolic acidosis.
• Solução de Ringer Simples (Simple Ringer's Solution) Balanced salt solution containing sodium, potassium, and calcium chlorides for fluid and electrolyte replacement in situations of fluid and ion loss.
• Solução de Glicerina 12% (Glycerin Solution 12%) Rectal solution acting as lubricant and emollient for impacted feces, promoting peristalsis and evacuation for complete intestinal cleansing in pre and post-operative care.
• Frasco para Nutrição Enteral (Enteral Nutrition Bottle) Bottle designed for packaging and administering enteral nutrition prepared in hospitals for maintaining or recovering patient nutritional status.

Quantifiable outcome

• Reduction of medication errors up to 50% through DataMatrix electronic verification
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered major and core.

• PfizermajorStrategic or Co-development PartnerDuring the COVID-19 pandemic, Equiplex supplied medications to Pfizer and PAHO (Pan-American Health Organization) to serve 8 countries, demonstrating international partnership capabilities and quality standards meeting global pharmaceutical requirements.
• PAHO (Pan-American Health Organization)majorStrategic or Co-development PartnerPartnership during pandemic to supply essential medications to 8 countries across Latin America, demonstrating international public health collaboration and emergency response capabilities.
• HospdrogascoreChannel Partner/ Reseller/ DistributorGroup company distributor for generic and similar medications. Equiplex produces medications under demand for Hospdrogas distribution, creating internal synergy within the H. Egidio Group.
• GS1 BrasilcoreTechnology or IntegrationPartnership for GS1 DataMatrix implementation and traceability standards compliance. GS1 provides the prefix and standards for unique product identification, batch tracking, and serialization required by Brazilian ANVISA regulations.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Baxter International: Global leader in parenteral and IV solutions; directly comparable product portfolio to Equiplex's small/large volume injectables, with much broader scale and geographic reach. Operates as a broad incumbent supplying hospitals worldwide.
• Fresenius Kabi: Specializes in clinical nutrition, IV drugs, and medical devices for hospital settings; a global direct competitor in the large/small volume parenteral solutions and sterile injectables market that Equiplex serves.
• EMS (Grupo EMS): Brazil's largest pharmaceutical company by revenue and a leader in generics; directly competes with Equiplex's planned generic expansion and is a benchmark competitor CEO Massillon Araujo referenced in his prior experience.
• Hypera Pharma: Brazil's largest pharma by market cap with leadership in generics and hospital brands; provides the most relevant domestic benchmark for Equiplex's generic expansion strategy and is one of the CEO's former employers.
• Eurofarma Laboratórios: Large Brazilian multinational generics and branded pharma company; relevant peer because of its generics segment overlap and Latin American export footprint comparable to Equiplex's international ambitions.
• Aché Laboratórios: Brazilian pharma major with diversified portfolio including hospital injectables; comparable domestic scale and competes for the same hospital and SUS procurement contracts that are central to Equiplex's revenue base.

Direct peers

• B. Braun: Family-owned German medical device and pharmaceutical company with deep parenteral solutions / IV fluids business; competes head-to-head with Equiplex's portfolio of sterile injectable solutions and shares Equiplex's preference for European manufacturing technology.
• Laboratórios Cristália: Brazilian hospital-focused pharmaceutical manufacturer with deep portfolio in injectables, anesthetics, and sterile solutions; the closest direct competitor in Equiplex's hospital segment and also a prior employer of the current CEO.

Emerging players

• Aspen Pharmacare: South African-headquartered specialty pharma with growing global sterile injectables and generics business; relevant emerging-market peer for Equiplex's Latin American export push and product-line diversification trajectory.
• Lupin Pharmaceuticals: India-headquartered generics major with meaningful sterile injectable franchise; cited as a former employer of Equiplex's CEO and a relevant emerging-market comparator on injectable generics, though focused on different geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/equiplex
• LinkedInlinkedin.com/company/equiplex-ind-stria-farmac-utica
• Instagraminstagram.com/equiplex

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Equiplex